Iterum Therapeutics Statistics
Total Valuation
ITRM has a market cap or net worth of $20.81 million. The enterprise value is $22.04 million.
Market Cap | 20.81M |
Enterprise Value | 22.04M |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, before market open.
Earnings Date | Aug 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ITRM has 16.55 million shares outstanding. The number of shares has increased by 21.69% in one year.
Shares Outstanding | 16.55M |
Shares Change (YoY) | +21.69% |
Shares Change (QoQ) | +17.07% |
Owned by Insiders (%) | 1.34% |
Owned by Institutions (%) | 5.65% |
Float | 16.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.07
Current Ratio | 1.07 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -22.12 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -104.20% |
Return on Capital (ROIC) | -323.49% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.54M |
Employee Count | 14 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ITRM has paid $538,000 in taxes.
Income Tax | 538,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.49% in the last 52 weeks. The beta is 2.25, so ITRM's price volatility has been higher than the market average.
Beta (5Y) | 2.25 |
52-Week Price Change | +7.49% |
50-Day Moving Average | 1.34 |
200-Day Moving Average | 1.43 |
Relative Strength Index (RSI) | 44.16 |
Average Volume (20 Days) | 270,422 |
Short Selling Information
The latest short interest is 1.28 million, so 7.74% of the outstanding shares have been sold short.
Short Interest | 1.28M |
Short Previous Month | 1.27M |
Short % of Shares Out | 7.74% |
Short % of Float | 7.89% |
Short Ratio (days to cover) | 8.85 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -45.10M |
Pretax Income | -35.05M |
Net Income | -35.58M |
EBITDA | -32.21M |
EBIT | -33.53M |
Earnings Per Share (EPS) | -$2.65 |
Balance Sheet
The company has $18.25 million in cash and $20.09 million in debt, giving a net cash position of -$1.84 million or -$0.11 per share.
Cash & Cash Equivalents | 18.25M |
Total Debt | 20.09M |
Net Cash | -1.84M |
Net Cash Per Share | -$0.11 |
Equity (Book Value) | -6.15M |
Book Value Per Share | -0.37 |
Working Capital | 1.26M |
Cash Flow
In the last 12 months, operating cash flow was -$42.82 million and capital expenditures -$13,000, giving a free cash flow of -$42.84 million.
Operating Cash Flow | -42.82M |
Capital Expenditures | -13,000 |
Free Cash Flow | -42.84M |
FCF Per Share | -$2.78 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ITRM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -21.69% |
Shareholder Yield | -21.69% |
Earnings Yield | -176.18% |
FCF Yield | -212.09% |
Analyst Forecast
The average price target for ITRM is $6.00, which is 380.00% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $6.00 |
Price Target Difference | 380.00% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 18, 2022. It was a reverse split with a ratio of 1:15.
Last Split Date | Aug 18, 2022 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |